Zero-shot removal of PHI from clinical free-text using GPT-4

Zero-shot removal of PHI from clinical free-text using GPT-4 targets a $3.6B = 120,000 clinical data teams × $30K ACV total addressable market with medium saturation and a year-over-year growth rate of 12% CAGR — based on combined growth of healthcare data analytics, healthtech AI tools, and data privacy/anonymization market reports (industry analyst synthesis, 2022-2025).

Key trends driving demand: LLMs improving entity extraction — higher zero/few-shot accuracy creates an opportunity to reduce labeling costs and speed product development.; Regulatory and research initiatives pushing data sharing — mandates and incentives for real-world evidence and multi-institutional research increase demand for de-identification.; Cloud and VPC deployment parity — enterprises expect secure, auditable deployments with SOC/HIPAA compliance, enabling SaaS adoption for sensitive healthcare workflows..